Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for LV Remodelling Post-Acute MI
NCT00132093Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Eplerenone with Placebo (2 arms). Primary endpoint: Change in Left Ventricular End-Systolic Volume at 6 months. Started Apr 2005; status: completed.
02
Drugs
eplerenone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00132093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132093.